Skip to main content

Assessment of anxiety and depression among hospitalized COVID-19 patients in Thailand during the first wave of the pandemic: a cross-sectional study

Abstract

Anxiety and depression in hospitalized COVID-19 patients in Thailand during the first wave of the pandemic were investigated. Thai version of Hospital Anxiety and Depression Scale (HADS) was chosen as an instrument for evaluation. Thirty-two voluntary participants completed the questionnaire. Three (9.4%) respondents had abnormal anxiety sub-scale scores while no respondents had abnormal depression sub-scale scores. There was no statistical demographic difference between the anxiety and non-anxiety groups.

To the editor,

Introduction

COVID-19 patients have been identified as vulnerable groups that might develop serious mental health consequences [1]. Uncertain clinical progression by a novel pathogen and patient isolation might lead to psychological distress in patients [2]. Hence, our study aims to evaluate the mental health of these patients.

Main text

Fifty-two hospitalized PCR-confirmed non-severe COVID-19 patients older than 18 years admitted at Bamrasnaradura Infectious Disease Institute in April 2020 during the first wave of pandemic were invited to participate. The Hospital Anxiety and Depression Scale (HADS) [3] was used to measure anxiety and depression. It consisted of a 7-item anxiety sub-scale (HADS-A) and a 7-item depression sub-scale (HADS-D). HADS was translated in Thai and had been validated in hospitalized patients [4]. The questionnaire was completed within the first 5 days of admission and was analyzed by the physician. Demographic data were reported by descriptive statistics. Two-tailed Fisher’s exact test and two-tailed t-test were used to compare categorical variables and continuous variables, respectively. All statistical analyses were performed in Microsoft Excel 2013.

Thirty-two hospitalized COVID-19 patients voluntarily completed the questionnaire. The mean ± standard deviation (SD) of HADS-A score was 6.7 ± 3.7 while the mean ± SD of HADS-D score was 4.1 ± 2.8. When using the cut-off scores at 11, three participants (9.4%) had abnormal HADS-A scores while no participants had abnormal HADS-D scores. Participants with abnormal HADS-A score were properly evaluated by a psychologist. Further analysis revealed no statistical difference in demographic characteristics between anxious and non-anxious participants (Table 1).

Table 1 Characteristics comparison between anxiety and non-anxiety participants

From the literature review, several studies assess anxiety and depression in hospitalized COVID-19 patients by using HADS. Three hospitals in China revealed that the prevalence of admitted COVID-19 patients with abnormal HADS-A score is 20.9–41.5% while the prevalence of patients with abnormal HADS-D score is 18.6–50.5% [5,6,7]. Two studies from South Korea conducted in hospitalized COVID-19 patients showed that 10.3–18% of participants had abnormal HADS-A score, whereas 15.9–39% of participants had abnormal HADS-D score [8, 9]. Furthermore, an evaluation of anxiety and depression among admitted COVID-19 patients in Turkey demonstrated that 34.9% and 42.0% of participants had abnormal HADS-A score and abnormal HADS-D score, respectively [10].

The biological effect of SARS-CoV-2 on the brain causing neuropsychiatric symptoms is not well-established, but possible mechanisms include neuroinflammation, altered neurotransmitter, and neuronal damage [11]. For psychosocial stressors, the uncertainty of disease progression, welfare concern of quarantined contact people who might be infected, and an obstacle of mental support from visitors in the isolation ward can contribute to the development of anxiety in these vulnerable patients. Nevertheless, our study is limited by a small sample size due to the decline of patients during the duration of our study.

Conclusions

In summary, we suggested that mental health assessment is crucial for the hospitalized COVID-19 patient to explore psychological distress which might require intervention to prevent further psychological complications. Our study and other studies conducted overseas demonstrated that HADS can be used to assess depression and anxiety in hospitalized COVID-19 patients.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

HADS:

Hospital Anxiety and Depression Scale

HADS-A:

Anxiety sub-scale of HADS

HADS-D:

Depression sub-scale of HADS

SD:

Standard deviation

References

  1. 1.

    Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: mental health consequences and target populations. Psychiatry Clin Neurosci. 2020;74:281–2.

    CAS  Article  Google Scholar 

  2. 2.

    Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7:228–9.

    Article  Google Scholar 

  3. 3.

    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

    CAS  Article  Google Scholar 

  4. 4.

    Nilchaikovit T, Lotrakul M, Phisansuthideth U. Development of Thai version of Hospital Anxiety and Depression Scale in cancer patients. J Psychiatr Assoc Thailand. 1996;41:18–30.

    Google Scholar 

  5. 5.

    Kong X, Kong F, Zheng K, Tang M, Chen Y, Zhou J, et al. Effect of psychological-behavioral intervention on the depression and anxiety of COVID-19 patients. Front Psychiatry. 2020;11:586355.

    Article  Google Scholar 

  6. 6.

    Zhang J, Yang Z, Wang X, Li J, Dong L, Wang F, et al. The relationship between resilience, anxiety and depression among patients with mild symptoms of COVID-19 in China: a cross-sectional study. J Clin Nurs. 2020;29:4020–9.

    Article  Google Scholar 

  7. 7.

    Li X, Tian J, Xu Q. The associated factors of anxiety and depressive symptoms in COVID-19 patients hospitalized in Wuhan, China. Psychiatr Q. 2020;1–9. https://doi.org/10.1007/s11126-020-09865-9.

  8. 8.

    Kim JW, Stewart R, Kang SJ, Jung SI, Kim SW, Kim JM. Telephone based interventions for psychological problems in hospital isolated patients with COVID-19. Clin Psychopharmacol Neurosci. 2020;18:616–20.

    CAS  Article  Google Scholar 

  9. 9.

    Jeong SJ, Chung WS, Sohn Y, Hyun JH, Baek YJ, Cho Y, et al. Clinical characteristics and online mental health care of asymptomatic or mildly symptomatic patients with coronavirus disease 2019. PLoS ONE. 2020;15:e0242130.

    CAS  Article  Google Scholar 

  10. 10.

    Şahan E, Ünal SM, Kırpınar İ. Can we predict who will be more anxious and depressed in the COVID-19 ward? J Psychosom Res. 2021;140:110302.

    Article  Google Scholar 

  11. 11.

    Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiat. 2021;78:682–3.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

None.

Author information

Affiliations

Authors

Contributions

WT: conceptualization, data curation, formal analysis, investigation, methodology, resources, visualization, writing—original draft, writing—review and editing. WAP: conceptualization, methodology, project administration, resources, writing—review and editing. WP: conceptualization, methodology, supervision, writing—review and editing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Wajana Thaweerat.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Institutional Review Board of Bamrasnaradura Infectious Disease Institute (IRB No. S009h/63_ExPD). Written informed consent was obtained from each participant in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Thaweerat, W., Pongpirul, W.A. & Prasithsirikul, W. Assessment of anxiety and depression among hospitalized COVID-19 patients in Thailand during the first wave of the pandemic: a cross-sectional study. Egypt J Neurol Psychiatry Neurosurg 57, 106 (2021). https://doi.org/10.1186/s41983-021-00362-9

Download citation

Keywords

  • Anxiety
  • COVID-19
  • Depression
  • Psychological tests